Pearl Freier is the founder of Cambridge BioPartners, Inc. in Cambridge, MA, with recognized expertise in biotech and life sciences. She actively engages in discussions on pharmaceutical manufacturing, drug shortages, and regulatory policies impacting medical innovation. Her leadership and insights emphasize her role in advancing biotech collaborations and addressing public health challenges.

‌